A Role of the Aryl Hydrocarbon Receptor in Attenuation of Colitis

作者:Furumatsu Keisuke; Nishiumi Shin; Kawano Yuki; Ooi Makoto; Yoshie Tomoo; Shiomi Yuuki; Kutsumi Hiromu; Ashida Hitoshi; Fujii Kuriyama Yoshiaki; Azuma Takeshi; Yoshida Masaru*
来源:Digestive Diseases and Sciences, 2011, 56(9): 2532-2544.
DOI:10.1007/s10620-011-1643-9

摘要

The aryl hydrocarbon receptor (AhR), which is a member of the basic helix-loop-helix/Per-Arnt-Sim homology superfamily, plays an important role in multiple biological functions, and AhR knockout (AhR KO) animals suffer from a variety of organ disorders including a decline in the efficacy of their immune system. In addition, AhR activation is known to aid the maintenance of homeostasis in vivo. In this study, we investigated whether AhR is functionally associated with intestinal immunity. In in vivo experiments, it was found that dextran sodium sulfate (DSS)-evoked colitis was more severe in AhR KO mice than in C57BL/6J wild type mice. It was also revealed that the administration of DSS increased the expression levels of AhR and CYP1A1 mRNA in the colon epithelium. In addition, oral administration of beta-naphthoflavone (beta NF), a non-toxic agonist of AhR, suppressed the pathogenesis of DSS-induced colitis. beta NF also attenuated DSS-induced colitis. In cell culture experiments, downregulation of AhR in human colon carcinoma SW480 cells enhanced the inflammatory responses evoked by lipopolysaccharide (LPS), and furthermore, AhR activation attenuated LPS-induced inflammatory responses, suggesting that AhR expressing intestinal epithelial cells are involved in the prevention of colitis. Our findings about the potential role of AhR activators in epithelial immune regulation aid our understanding of mucosal homeostasis and inflammatory bowl disease (IBD) and suggest that AhR activation has therapeutic value for the treatment of IBD.

  • 出版日期2011-9